Deferasirox Oral Granules Granule
Product Images NDC 42806-372

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Deferasirox Oral Granules (NDC 42806-372). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Epic Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton-180mg.jpg (Carton 180mg)

FDA Label Image

Carton-360mg.jpg (Carton 360mg)

FDA Label Image

Carton-90mg.jpg (Carton 90mg)

FDA Label Image

Figure-1.jpg (Figure 1)

FDA Label Image

Sachet-180mg.jpg (Sachet 180mg)

FDA Label Image

Sachet-360mg.jpg (Sachet 360mg)

Sachet-360mg.jpg (Sachet 360mg)
This is the description of a medication called Deferasirox, available in the form of Oral Granules. The NDC (National Drug Code) for this medication is 2806-373-30. Each sachet of Oral Granules contains 648 mg of granules which are equivalent to 360 mg of Deferasirox. The medication is available for prescription use only.*
FDA Label Image

Sachet-90mg.jpg (Sachet 90mg)

Sachet-90mg.jpg (Sachet 90mg)
This is a description of a medication called "Deferasirox" in granule form, available only with a prescription. Each sachet contains 162 mg granule equivalent to 90 mg deferasirox. It is manufactured by Epic Pharma, LLC and the label provides a phone number and an address for their offices in New York.*
FDA Label Image

Structural-formula.jpg (Structural Formula)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.